EMA — authorised 3 August 2001
- Status: approved
EMA authorised Replagal on 3 August 2001
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 3 August 2001.
Marketing authorisation holder not available in our data.